Cargando…

Interventional bundle for venous thromboembolism prevention: ensuring quality and effectiveness

Hospital-associated thromboses (HATs) are a potentially preventable cause of morbidity and mortality. Oxford University Hospitals NHS Foundation Trust was designated a Venous Thromboembolism (VTE) Exemplar Centre by NHS England in 2014. However, following delayed reporting of a potentially preventab...

Descripción completa

Detalles Bibliográficos
Autores principales: Shapiro, Susan, Dunnigan, Anna, Keen, Sarah, Clarke, Penney
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590969/
https://www.ncbi.nlm.nih.gov/pubmed/31297454
http://dx.doi.org/10.1136/bmjoq-2018-000459
_version_ 1783429655498326016
author Shapiro, Susan
Dunnigan, Anna
Keen, Sarah
Clarke, Penney
author_facet Shapiro, Susan
Dunnigan, Anna
Keen, Sarah
Clarke, Penney
author_sort Shapiro, Susan
collection PubMed
description Hospital-associated thromboses (HATs) are a potentially preventable cause of morbidity and mortality. Oxford University Hospitals NHS Foundation Trust was designated a Venous Thromboembolism (VTE) Exemplar Centre by NHS England in 2014. However, following delayed reporting of a potentially preventable HAT in 2015, a benchmarking exercise suggested HATs were being under-reported, and also that the established hospital-wide audits of VTE prevention had significant limitations. The aim of this interventional bundle was to ensure high-quality data for key VTE prevention measures across the hospital, to identify areas for improvement and demonstrate a reduction in the number of potentially preventable HATs over a 2-year period. The project team engaged with hospital leadership and collaborated with hospital-wide stakeholders. A multifaceted approach was taken and ‘Plan Do Study Act’ cycles were used to test interventions with continuous evaluation of impact. The percentage of inpatients receiving appropriate thromboprophylaxis progressively increased from 94% to 98%. The project did not achieve its secondary aim of a reduction in the number of potentially preventable HATs. Revision of the HAT reporting process resulted in better detection and an initial increase in reporting of potentially preventable HATs, although data suggest that the level of harm from errors is now reducing. The improvement in overall appropriate thromboprophylaxis is considered to be due to robust audits of appropriate thromboprophylaxis, upskilling of ward pharmacists, improved detection of potentially preventable HATs resulting in additional safety nets such as linking the ‘outcome recommendation’ of the electronic VTE risk assessment directly to electronic prescribing, and increased awareness and education. Combining low-cost actions in a coordinated interventional bundle has produced measurable improvements in our VTE management programme, enhancing patient safety. We believe the model to be sustainable and replicable in other general hospitals.
format Online
Article
Text
id pubmed-6590969
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-65909692019-07-11 Interventional bundle for venous thromboembolism prevention: ensuring quality and effectiveness Shapiro, Susan Dunnigan, Anna Keen, Sarah Clarke, Penney BMJ Open Qual BMJ Quality Improvement report Hospital-associated thromboses (HATs) are a potentially preventable cause of morbidity and mortality. Oxford University Hospitals NHS Foundation Trust was designated a Venous Thromboembolism (VTE) Exemplar Centre by NHS England in 2014. However, following delayed reporting of a potentially preventable HAT in 2015, a benchmarking exercise suggested HATs were being under-reported, and also that the established hospital-wide audits of VTE prevention had significant limitations. The aim of this interventional bundle was to ensure high-quality data for key VTE prevention measures across the hospital, to identify areas for improvement and demonstrate a reduction in the number of potentially preventable HATs over a 2-year period. The project team engaged with hospital leadership and collaborated with hospital-wide stakeholders. A multifaceted approach was taken and ‘Plan Do Study Act’ cycles were used to test interventions with continuous evaluation of impact. The percentage of inpatients receiving appropriate thromboprophylaxis progressively increased from 94% to 98%. The project did not achieve its secondary aim of a reduction in the number of potentially preventable HATs. Revision of the HAT reporting process resulted in better detection and an initial increase in reporting of potentially preventable HATs, although data suggest that the level of harm from errors is now reducing. The improvement in overall appropriate thromboprophylaxis is considered to be due to robust audits of appropriate thromboprophylaxis, upskilling of ward pharmacists, improved detection of potentially preventable HATs resulting in additional safety nets such as linking the ‘outcome recommendation’ of the electronic VTE risk assessment directly to electronic prescribing, and increased awareness and education. Combining low-cost actions in a coordinated interventional bundle has produced measurable improvements in our VTE management programme, enhancing patient safety. We believe the model to be sustainable and replicable in other general hospitals. BMJ Publishing Group 2019-06-21 /pmc/articles/PMC6590969/ /pubmed/31297454 http://dx.doi.org/10.1136/bmjoq-2018-000459 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle BMJ Quality Improvement report
Shapiro, Susan
Dunnigan, Anna
Keen, Sarah
Clarke, Penney
Interventional bundle for venous thromboembolism prevention: ensuring quality and effectiveness
title Interventional bundle for venous thromboembolism prevention: ensuring quality and effectiveness
title_full Interventional bundle for venous thromboembolism prevention: ensuring quality and effectiveness
title_fullStr Interventional bundle for venous thromboembolism prevention: ensuring quality and effectiveness
title_full_unstemmed Interventional bundle for venous thromboembolism prevention: ensuring quality and effectiveness
title_short Interventional bundle for venous thromboembolism prevention: ensuring quality and effectiveness
title_sort interventional bundle for venous thromboembolism prevention: ensuring quality and effectiveness
topic BMJ Quality Improvement report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590969/
https://www.ncbi.nlm.nih.gov/pubmed/31297454
http://dx.doi.org/10.1136/bmjoq-2018-000459
work_keys_str_mv AT shapirosusan interventionalbundleforvenousthromboembolismpreventionensuringqualityandeffectiveness
AT dunnigananna interventionalbundleforvenousthromboembolismpreventionensuringqualityandeffectiveness
AT keensarah interventionalbundleforvenousthromboembolismpreventionensuringqualityandeffectiveness
AT clarkepenney interventionalbundleforvenousthromboembolismpreventionensuringqualityandeffectiveness